Advances and new perspectives in the treatment of metastatic colon cancer

Por Recondo, Gonzalo Jr, Díaz-Cantón, Enrique, de la Vega, Máximo, Greco, Martin, Recondo, Gonzalo Sr, Valsecchi, Matias E
Publicado em 2014

Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions

Por Recondo, Gonzalo Jr, Dìaz Canton, Enrique, de la Vega, Màximo, Greco, Martin, Recondo, Gonzalo Sr, Valsecchi, Matias E
Publicado em 2014

Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine

Por Recondo, Gonzalo, de la Vega, Maximo, Galanternik, Fernando, Díaz-Cantón, Enrique, Leone, Bernardo Amadeo, Leone, José Pablo
Publicado no Cancer Manag Res (2016)

Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice

Por Solano, Angela Rosaria, Cardoso, Florencia Cecilia, Romano, Vanesa, Perazzo, Florencia, Bas, Carlos, Recondo, Gonzalo, Santillan, Francisco Bernardo, Gonzalez, Eduardo, Abalo, Eduardo, Viniegra, María, Michel, José Davalos, Nuñez, Lina María, Noblia, Cristina Maria, Mc Lean, Ignacio, Canton, Enrique Diaz, Chacon, Reinaldo Daniel, Cortese, Gustavo, Varela, Eduardo Beccar, Greco, Martín, Barrientos, María Laura, Avila, Silvia Adela, Vuotto, Hector Daniel, Lorusso, Antonio, Podesta, Ernesto Jorge, Mando, Oscar Gaspar
Publicado no Oncotarget (2016)